nicotinuric acid has been researched along with niacin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (26.92) | 18.7374 |
| 1990's | 5 (19.23) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 9 (34.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bemis, JE; Benson, E; Bista, P; Carney, D; Fahrner, R; Jirousek, MR; Lee, D; Liu, F; Lonkar, P; Milne, JC; Nichols, AJ; Picarella, D; Shoelson, A; Smith, J; Ting, A; Vu, CB; Wensley, A; Yeager, M; Zimmer, M | 1 |
| Freeman, D; Spence, JD; Stern, RH | 1 |
| Freeman, DJ; Parbtani, A; Spence, JD; Stern, RH | 1 |
| Kakehi, H; Matsuo, H; Shibata, K | 1 |
| Figge, HL; Figge, J; Janosik, JE; Kaul, AF; Sacks, FM; Shargel, L; Souney, PF | 1 |
| Arita, T; Miyazaki, K; Takikawa, K | 1 |
| Miyauchi, Y; Nakamura, T; Sano, N | 1 |
| Benet, LZ; Hayashi, H; Iwaki, M; Ogiso, T; Tanino, T | 1 |
| ELLIOTT, WH; JONES, EM | 1 |
| JONES, KM | 2 |
| BANERJEE, S; GHOSH, NC; NANDI, N | 1 |
| BOCCARDELLI, V; NICHELE, G | 1 |
| Baumeister, A; Häring, N; Kärcher, U; Pfuhl, P; Schubert-Zsilavecz, M; Tawab, MA | 1 |
| Kamanna, VS; Kashyap, ML; Liu, P; Meyers, CD | 1 |
| Adams, MH; Cefali, EA; González, MA; Leu, JH; Menon, RM; Tolbert, DS | 2 |
| Cefali, E; Menon, R; Tolbert, D | 1 |
| Bode-Böger, SM; Luley, C; Martens-Lobenhoffer, J; Reiche, I; Tröger, U; Westphal, S | 1 |
| Damaramadugu, R; Inamadugu, JK; Mullangi, R; Ponneri, V | 1 |
| Cutler, DL; Kim, KT; Kosoglou, T; Statkevich, P; Taggart, W; Triantafyllou, I; Xuan, F; Zhu, Y | 1 |
| Gong, XL; Liang, MZ; Nan, F; Qin, YP; Wang, L; Xiang, J; Yu, Q | 1 |
| Couturier, A; Eder, K; Keller, J; Most, E; Ringseis, R | 1 |
| Fukuwatari, T; Shibata, K; Suzuki, C | 1 |
| De Kam, PJ; Farrell, C; Fitzpatrick, S; Kesisoglou, F; Prohn, M; Rossenu, S; Van Den Heuvel, M; Vargo, R | 1 |
| Abia, R; Bermudez, B; Lopez, S; Montserrat-de la Paz, S; Muriana, FJG; Naranjo, MC | 1 |
6 trial(s) available for nicotinuric acid and niacin
| Article | Year |
|---|---|
Effect of the rate of niacin administration on the plasma and urine pharmacokinetics of niacin and its metabolites.
Topics: Adult; Area Under Curve; Drug Administration Schedule; Humans; Male; Middle Aged; Niacin; Niacinamide; Nicotinic Acids; Vitamin B Complex | 2007 |
The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; Cross-Over Studies; Delayed-Action Preparations; Drug Combinations; Female; Flushing; Humans; Lovastatin; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Niacin; Niacinamide; Nicotinic Acids; Pyridones; Tablets; Time Factors; Vitamin B Complex | 2007 |
Plasma and urine pharmacokinetics of niacin and its metabolites from an extended-release niacin formulation.
Topics: Adult; Cross-Over Studies; Delayed-Action Preparations; Humans; Male; Middle Aged; Niacin; Niacinamide; Nicotinic Acids; Vitamins | 2007 |
Simultaneous determination of niacin and its metabolites--nicotinamide, nicotinuric acid and N-methyl-2-pyridone-5-carboxamide--in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
Topics: Chromatography, Liquid; Drug Stability; Humans; Linear Models; Male; Nevirapine; Niacin; Niacinamide; Nicotinic Acids; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
Assessment of potential pharmacokinetic interactions of ezetimibe/simvastatin and extended-release niacin tablets in healthy subjects.
Topics: Adult; Anticholesteremic Agents; Azetidines; Cross-Over Studies; Delayed-Action Preparations; Drug Interactions; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypolipidemic Agents; Lipids; Male; Niacin; Nicotinic Acids; Simvastatin; Tablets | 2011 |
Development of in vitro-in vivo correlation for extended-release niacin after administration of hypromellose-based matrix formulations to healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Biotransformation; Chemistry, Pharmaceutical; Cross-Over Studies; Delayed-Action Preparations; Drug Carriers; Excipients; Healthy Volunteers; Humans; Hypromellose Derivatives; Middle Aged; Models, Biological; Niacin; Nicotinic Acids; Renal Elimination; Reproducibility of Results; Solubility; Technology, Pharmaceutical; Young Adult | 2014 |
20 other study(ies) available for nicotinuric acid and niacin
| Article | Year |
|---|---|
Synthesis and Characterization of Fatty Acid Conjugates of Niacin and Salicylic Acid.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Dogs; Dose-Response Relationship, Drug; Fatty Acids; Hep G2 Cells; Humans; Hydrolysis; Liver; Mice; Molecular Structure; NF-kappa B; Niacin; Rats; Rats, Sprague-Dawley; Salicylic Acid; Sterol Regulatory Element Binding Protein 1; Sterol Regulatory Element Binding Protein 2; Structure-Activity Relationship; Tissue Distribution | 2016 |
Differences in metabolism of time-release and unmodified nicotinic acid: explanation of the differences in hypolipidemic action?
Topics: Adult; Analysis of Variance; Delayed-Action Preparations; Humans; Lipids; Male; Niacin; Nicotinic Acids; Pyridones | 1992 |
Tolerance to nicotinic acid flushing.
Topics: Administration, Oral; Dinoprost; Drug Tolerance; Humans; Niacin; Nicotinic Acids; Radioimmunoassay; Skin | 1991 |
Niacin catabolism in rodents.
Topics: Animals; Cricetinae; Guinea Pigs; Kinetics; Male; Mice; Mice, Inbred ICR; Niacin; Niacinamide; Nicotinic Acids; Species Specificity | 1990 |
Comparison of excretion of nicotinuric acid after ingestion of two controlled release nicotinic acid preparations in man.
Topics: Adult; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Humans; Male; Niacin; Nicotinic Acids; Solubility; Tablets | 1988 |
High-performance liquid chromatographic determination of nicotinic acid and its metabolites, nicotinuric acid and nicotinamide, in plasma.
Topics: Chromatography, High Pressure Liquid; Humans; Niacin; Niacinamide; Nicotinic Acids | 1982 |
Simultaneous determination of nicotinic acid and its two metabolites in human plasma using solid-phase extraction in combination with high performance liquid chromatography.
Topics: Adult; Chromatography, High Pressure Liquid; Humans; Male; Niacin; Niacinamide; Nicotinic Acids; Reproducibility of Results; Sensitivity and Specificity; Time Factors | 1993 |
Acute dose-dependent disposition studies of nicotinic acid in rats.
Topics: Animals; Blood Proteins; Dose-Response Relationship, Drug; Models, Biological; Niacin; Nicotinic Acids; Protein Binding; Rats; Rats, Wistar | 1996 |
The synthesis of nicotinuric acid by rat-kidney preparations.
Topics: Animals; Fabaceae; Glycine; Kidney; Niacin; Nicotinic Acids; Rats | 1959 |
The mechanism of nicotinuric acid synthesis.
Topics: Fabaceae; Glycine; Niacin; Nicotinic Acids | 1959 |
A chromatographic method for the estimation of nicotinuric acid and nicotinamide.
Topics: Fabaceae; Glycine; Niacin; Niacinamide; Nicotinic Acids | 1959 |
Studies on the biosynthesis of nicotinic acid. Part III. Effect of germination on the nicotinic-acid, nicotinuric-acid, N1-methyl-nicotinamide and trigonelline values of pulses and cereals.
Topics: Alkaloids; Edible Grain; Germination; Niacin; Niacinamide; Nicotinic Acids; Plants; Pulse | 1951 |
[Studies on urinary elimination of nicotinic acid, nicotinuric acid, and trigonelline in nicotinic acid and its amides tolerance tests].
Topics: Alkaloids; Amides; Anesthetics, Local; Chlortetracycline; Humans; Niacin; Nicotinic Acids | 1951 |
Simultaneous determination of niacin, niacinamide and nicotinuric acid in human plasma.
Topics: Humans; Niacin; Niacinamide; Nicotinic Acids | 2005 |
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: an in vitro model of the niacin flush.
Topics: Aspirin; Calcimycin; Calcium; Flushing; Humans; Macrophages; Models, Biological; Niacin; Nicotinic Acids; Prostaglandin D2; Tumor Cells, Cultured | 2007 |
Pharmacokinetics and dose recommendations of Niaspan® in chronic kidney disease and dialysis patients.
Topics: Aged; Chronic Disease; Cohort Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypolipidemic Agents; Kidney Diseases; Male; Middle Aged; Niacin; Niacinamide; Nicotinic Acids; Prospective Studies; Renal Dialysis; Survival Rate; Tissue Distribution; Treatment Outcome | 2011 |
[Determination of nicacid and its metabolites in human plasma by HPLC-MS/MS].
Topics: Chromatography, High Pressure Liquid; Humans; Niacin; Niacinamide; Nicotinic Acids; Tandem Mass Spectrometry | 2010 |
Niacin in pharmacological doses alters microRNA expression in skeletal muscle of obese Zucker rats.
Topics: Animals; Body Weight; Computational Biology; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Male; MicroRNAs; Muscle, Skeletal; Niacin; Niacinamide; Nicotinic Acids; Oligonucleotide Array Sequence Analysis; Phenotype; Rats; Rats, Zucker; RNA, Messenger; Signal Transduction; Vitamin B Complex | 2014 |
Pharmacological doses of nicotinic acid and nicotinamide are independently metabolized in rats.
Topics: Animals; Diet; Drug Interactions; Male; Niacin; Niacinamide; Nicotinic Acids; Pyridones; Rats, Wistar | 2014 |
Niacin and its metabolites as master regulators of macrophage activation.
Topics: Anti-Inflammatory Agents; Antioxidants; Cell Differentiation; Cell Survival; Humans; Macrophage Activation; Monocytes; Niacin; Niacinamide; Nicotinic Acids; Nitric Oxide Synthase Type II; Oxidative Stress; Pyridones; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction | 2017 |